MTOR and lymphangioleiomyomatosis: To investigate the association of immunohistological features with impairment in PFTs, we evaluated morphological parameters related to tissue destruction, LAM cell infiltration, and the expression of proteins related to the mTOR pathway, angiogenesis and enzymatic activity in LAM patients with different functional severities.